Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

AVXLAVXL
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ANAVEX LIFE SCIENCES CORP

GOLDMAN SACHS GROUP INC holds 890,634 shares of AVXL (ANAVEX LIFE SCIENCES CORP), worth $2.3M as of 2026-Q2. The position was increased (+10.7% shares). AVXL represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$2.3M

Current Shares

890,634

Total Value Change

-$3.5M

Total Shares Change

+352,093

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
890,634
+10.7%
$2.3M0.0%$2.59
29
2026-Q1
Decreased
804,435
-7.8%
$2.5M0.0%$4.69
0
2025-Q4
Increased
872,968
+187.7%
$3.1M0.0%$3.80
43
2025-Q3
Increased
303,389
+3.3%
$2.7M0.0%$8.65
27
2025-Q2
Decreased
293,780
-28.6%
$2.7M0.0%$9.48
0
2025-Q1
Decreased
411,659
-23.6%
$3.5M0.0%$8.72
0
2024-Q4
New
538,541
-
$5.8M0.0%$11.04
38

Other major holders of AVXL: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used